Obesity and Its Relationship to Adverse Cardiovascular Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction in the I-PRESERVE Trial

被引：0
|
作者：
Kitzman, Dalane W. [1 ]
Haas, Marcus M. [2 ]
Carson, Peter E. [3 ,4 ]
Hetzel, Scott [5 ]
Komajda, Michael [6 ,7 ]
Zile, Michael [8 ,9 ]
Mckelvie, Robert [10 ]
Mcmurray, John J. [11 ]
Demets, D. [5 ]
Staiger, C. [13 ]
Ptaszynska, Agata [12 ]
Massie, Barry [14 ,15 ]
机构：
[1] Wake Forest Univ Hlth Sci, F-75634 Winston Salem, NC USA
[2] Theresienkrankenhaus, Mannheim, Germany
[3] Washington VAMC, Washington, DC 29425 USA
[4] Georgetown Univ, Washington, DC USA
[5] Univ Wisconsin, Madison, WI USA
[6] Univ Paris 06, Paris, France
[7] Grp Hosp Pitie Salpetriere, Paris, France
[8] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA
[9] Med Univ S Carolina, Charleston, SC 94143 USA
[10] McMaster Univ, Hamilton, ON, Canada
[11] British Heart Fdn, Glasgow Cardiovasc Rsch Cntr, Glasgow, Lanark, Scotland
[12] Bristol Myers Squibb Co, Princeton, NJ USA
[13] Sanofi Aventis, Bridgeport, CT USA
[14] San Francisco VA Med Ctr, San Francisco, CA USA
[15] Univ Calif San Francisco, San Francisco, CA USA
来源：
CIRCULATION | 2009年 / 120卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S757 / S758
页数：2
相关论文
共 50 条
  • [21] Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF PEF). Findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE)
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Donovan, Mark
    Ptaszynska, Agatha
    Massie, Barry M.
    Carson, Peter
    CIRCULATION, 2007, 116 (16) : 551 - 551
  • [22] The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial
    Gandhi, Parul U.
    Chow, Sheryl L.
    Rector, Thomas S.
    Krum, Henry
    Gaggin, Hanna K.
    McMurray, John J.
    Zile, Michael
    Komajda, Michel
    McKelvie, Robert S.
    Carson, Peter E.
    Januzzi, James L.
    Anand, Inder S.
    CIRCULATION, 2015, 132
  • [23] MARKERS OF EXTRACELLULAR MATRIX TURNOVER AND RISK OF DEATH IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS FROM I-PRESERVE
    Chow, Sheryl L.
    Krum, Henry
    O'Barr, Stephen A.
    Zile, Michael
    Carson, Peter
    Komajda, Michel
    McMurray, John
    Anand, Inderjit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A969 - A969
  • [24] HEART FAILURE WITH PRESERVED EJECTION FRACTION: MORTALITY RISK POST FIRST HOSPITALIZATION - DATA FROM I-PRESERVE
    Carson, Peter E.
    Zile, Michael
    McMurray, John
    McKelvie, Robert
    Komajda, Michel
    Hetzel, Scott
    DeMets, David
    Staiger, Christoph
    Ptaszynska, Agata
    Massie, Barry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [25] Prognostic value of baseline NT-proBNP and its interactions with irbesartan treatment in patients with heart failure and preserved ejection fraction: Findings from the I-PRESERVE trial
    Anand, I. S.
    Rector, T. S.
    Cleland, J. G.
    Kckelvie, R. S.
    Persson, H.
    Mcmurray, J. J.
    Zile, M.
    Komajda, M.
    Massie, B.
    Carson, P.
    EUROPEAN HEART JOURNAL, 2011, 32 : 495 - 495
  • [26] Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction findings from the irbesartan in heart failure with preserved systolic function trial (I-PRESERVE)
    Zile, Michael R.
    Komajda, Michel
    McKelvie, Robert
    McMurray, John
    Donovan, Mark
    Ptaszynska, Agata
    Carson, Peter
    Massie, Barry M.
    CIRCULATION, 2007, 116 (16) : 706 - 707
  • [27] Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve)
    McMurray, John J.
    Komajda, Michel
    McKelvie, Robert
    Zile, Michael
    Ptaszynska, Agata
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION, 2007, 116 (16) : 552 - 552
  • [28] Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)
    Boehm, Michael
    Perez, Ana-Cristina
    Jhund, Pardeep S.
    Reil, Jan C.
    Komajda, Michel
    Zile, Michael R.
    McKelvie, Robert S.
    Anand, Inder S.
    Massie, Barry M.
    Carson, Peter E.
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (07) : 778 - 787
  • [29] Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
    Abdul-Rahim, Azmil H.
    Perez, Ana-Cristina
    MacIsaac, Rachael L.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Carson, Peter E.
    Komajda, Michel
    McKelvie, Robert S.
    Zile, Michael R.
    Swedberg, Karl
    Yusuf, Salim
    Pfeffer, Marc A.
    Solomon, Scott D.
    Lip, Gregory Y. H.
    Lees, Kennedy R.
    McMurray, John J. V.
    EUROPEAN HEART JOURNAL, 2017, 38 (10) : 742 - 750
  • [30] I-PRESERVE SUB-STUDY: PLASMA COLLAGEN MARKERS IN THE PREDICTION OF DEATH AND HOSPITALISATION IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
    Schneider, Hans G.
    Krum, Henry
    Elsik, Maros
    Ptaszynska, Agata
    Black, Marion
    Anand, Inder
    Carson, Peter
    Massie, Barry
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S337 - S337
12345